Schedule 13G ownership disclosure

Capricor Therapeutics Inc

Common Stock · CUSIP: 14070B309

Event date: 2025-09-30

Filing-level shares
2,206,719
Percent of class
4.82%
  • The Vanguard Group

    Shares: 2,206,719 · Class: 4.82%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000102909-25-000120
Form type
SCHEDULE 13G/A
Filer
CAPRICOR THERAPEUTICS, INC.
CIK
CIK 1133869
Filed
Oct 30, 2025
Reporting period
Sep 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub